Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase Commences Collaborative Research with National

<< Previous

Bullboard Posts

Next >>

Comment by Kingpin68on Apr 09, 2021 8:13am

183 Views

Post# 32965242

RE:RE:Theralase Commences Collaborative Research with National

Yes, great news and hopefully more coming soon with the quarterly newsletter. I'm curious though why the news release had no mention of Dr. Coombs in-vivo research with small animal models over the last few months which was supposed to be happening. Either way, this is a great partnership.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management